Public Disclosure of the Filing of New Drug and Therapeutic Biologics Applications With the US Food and Drug Administration

This cross-sectional study reviews New Drug Applications for new molecular entities and Biologics License Applications for new and biosimilar biological products submitted to the US Food and Drug Administration to assess how frequently applicants disclose applications in the media.

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Intern Med
Main Authors: Chahal, Harinder Singh, Szeto, David, Chaudhry, Anam H., Sigelman, Daniel W., Kim, Stella, Lurie, Peter G.
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2019
Assuntos:
Research Letter
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6547098/
https://ncbi.nlm.nih.gov/pubmed/31157824
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamainternmed.2019.1213
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados